TradingForProfitPro

JONSON & JONSON D1

Long
NYSE:JNJ   Johnson & Johnson
The prices of shares of pharmaceutical companies have dropped significantly since the beginning of autumn. Like many other stock market assets. Today, the Coronovirus situation is starting to worsen! The number of patients and deaths is increasing every day. And this is not surprising. Because the vacation season is over and the inhabitants of the whole planet have gone to study and work. Increasing contact between people will certainly increase the number of sick people. Also, the onset of the cold season will contribute to new diseases. That will give an opportunity for pharmaceutical companies to make good profits. Johnson & Johnson also released a new drug for psoriasis. And he is actively working in other branches of medicine.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.